Table 2. Percentage nucleotide identities between the study sample sequences (all and from the captive colony only) and previously isolated LCMV and Lassa virus sequences*.
| Sequence | All study sequences, % | Captive colony sequences only, % |
|---|---|---|
| All study sequences | 93.6–100 | NS |
| Captive colony sequences only | NS | 97.4–100 |
| LCMV CIPV76001 Pasteur (AF095783; France) | 78.7–80.5 | 78.7–80.5 |
| LCMV CIP97001 (AF079517; France) | 79.4– 83.1 | 80.9–83.1 |
| LCMV Marseille (DQ286931; France) | 82.8– 83.9 | 82.8–83.5 |
| LCMV CH5871 (AF325215; Germany) | 81.6–83.1 | 81.6–83.1 |
| LCMV CH5692 (AF325214; Germany) | 81.3–82.8 | 81.3–82.8 |
| LCMV MX (EU195888; Slovakia) | 78.7–80.5 | 78.7–80.5 |
| LCMV Armstrong (M20869; USA) | 82.8– 85.8 | 83.9–85.8 |
| LCMV WE (M22138) | 82.0–84.3 | 82.0–84.3 |
| Lassa LP (AF181853) | 58.1–59.9 | 58.8–59.9 |
*LCMV, lymphocytic choriomeningitis virus; NS, not shown.